非洲裔人群1型糖尿病风险及祖先特异性遗传风险评分的效用
本研究利用ImmunoChip对1021例非洲裔1型糖尿病患者和2928例对照进行SNP分型,识别出非洲特异性及已知欧洲裔HLA单倍型与1型糖尿病风险显著相关,并发现6个欧洲裔定义的非HLA风险位点在非洲裔中显著关联。基于此开发的非洲特异性遗传风险评分(GRS)预测1型糖尿病风险曲线下面积达0.871,显著优于欧洲裔GRS和两个多基因风险评分。
要点
- 非洲特异性HLA单倍型HLA-DQA1*03:01-HLA-DQB1*02:01与1型糖尿病风险显著相关。
- 非洲特异性GRS预测1型糖尿病风险AUC为0.871,优于欧洲裔GRS。
- 该GRS有助于识别可从免疫监测中获益以早期发现胰岛自身免疫的个体。
核心结论
- 1型糖尿病遗传风险包括祖先特异性的疾病相关变异。
- 所开发的非洲特异性GRS在非洲裔人群中提供更好的1型糖尿病预测,并有助于识别需要免疫监测以早期发现胰岛自身免疫的个体。
研究设计与样本
- 研究纳入1021例非洲裔1型糖尿病患者和2928例对照参与者,使用ImmunoChip生成SNP数据。
- 采用SNP2HLA推断HLA I类和II类等位基因。
- 使用逻辑回归模型识别全基因组显著(P < 5.0 × 10-8)的SNP,并在已知欧洲裔风险位点中验证(P < 2.79 × 10-5)。
主要发现
- 非洲特异性HLA单倍型(HLA-DQA1*03:01-HLA-DQB1*02:01)和已知欧洲裔HLA单倍型(HLA-DRB1*03:01-HLA-DQA1*05:01-HLA-DQB1*02:01、HLA-DRB1*04:01-HLA-DQA1*03:01-HLA-DQB1*03:02)与1型糖尿病风险显著相关。
- 在欧洲裔定义的非HLA风险位点中,6个风险位点在非洲裔受试者中与1型糖尿病显著相关。
- 非洲特异性GRS对1型糖尿病风险提供强预测(AUC 0.871),在独立发现和验证队列中显著优于欧洲裔GRS和两个多基因风险评分。
临床怎么用
- 在非洲裔人群中可考虑使用非洲特异性GRS进行1型糖尿病风险预测。
- 该GRS可用于识别可能从免疫监测中获益以早期检测胰岛自身免疫的个体组。
局限性
- 研究仅纳入非洲裔参与者,未涉及其他祖先人群的验证。
- 原文未报告GRS在临床实践中的具体应用阈值或成本效益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Genetic risk scores (GRS) have been developed that differentiate individuals with type 1 diabetes from those with other forms of diabetes and are starting to be used for population screening; however, most studies were conducted in European-ancestry populations. This study identifies novel genetic variants associated with type 1 diabetes risk in African-ancestry participants and develops an African-specific GRS. RESEARCH DESIGN AND METHODS: We generated single nucleotide polymorphism (SNP) data with the ImmunoChip on 1,021 African-ancestry participants with type 1 diabetes and 2,928 control participants. HLA class I and class II alleles were imputed using SNP2HLA. Logistic regression models were used to identify genome-wide significant (P < 5.0 × 10-8) SNPs associated with type 1 diabetes in the African-ancestry samples and validate SNPs associated with risk in known European-ancestry loci (P < 2.79 × 10-5). RESULTS: African-specific (HLA-DQA1*03:01-HLA-DQB1*02:01) and known European-ancestry HLA haplotypes (HLA-DRB1*03:01-HLA-DQA1*05:01-HLA-DQB1*02:01, HLA-DRB1*04:01-HLA-DQA1*03:01-HLA-DQB1*03:02) were significantly associated with type 1 diabetes risk. Among European-ancestry defined non-HLA risk loci, six risk loci were significantly associated with type 1 diabetes in subjects of African ancestry. An African-specific GRS provided strong prediction of type 1 diabetes risk (area under the curve 0.871), performing significantly better than a European-based GRS and two polygenic risk scores in independent discovery and validation cohorts. CONCLUSIONS: Genetic risk of type 1 diabetes includes ancestry-specific, disease-associated variants. The GRS developed here provides improved prediction of type 1 diabetes in African-ancestry subjects and a means to identify groups of individuals who would benefit from immune monitoring for early detection of islet autoimmunity.
引用
- Onengut-Gumuscu S, Chen WM, Robertson CC, et al. Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score. Diabetes Care. 2019. PMID: 30659077. doi:10.2337/dc18-1727
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。